HB183: AN ACT relating to coverage for injectable epinephrine devices.
Legislative Summary
Create a new section of Subtitle 17A of KRS Chapter 304 to require health benefit plans to cover injectable epinephrine devices for persons 18 years of age and under; provide that the coverage shall not be subject to cost-sharing requirements; amend KRS 205.522, 205.6485, 18A.225, and 164.2871 to require Medicaid, KCHIP, the state employee health plan, and self-insured employer group health plans offered by the governing board of a state postsecondary education institution to comply with the 18-and-under injectable epinephrine device coverage requirement; EFFECTIVE January 1, 2023.
Demographic Impact
Overall analysis of equity impact
Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
